Testing effectiveness (Phase 2)Study completedNCT00333294What this trial is testingPhase II Iressa + Irradiation Followed by Chemo in NSCLCWho this might be right forNon-Small Cell Lung Cancer AstraZeneca 50
Testing effectiveness (Phase 2)Ended earlyNCT00509366What this trial is testingStudy Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Duke University 101
Testing effectiveness (Phase 2)Study completedNCT00051571What this trial is testingSafety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung CarcinomaWho this might be right forCarcinoma, Non-Small-Cell Lung Seagen Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01165021What this trial is testingPemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Eli Lilly and Company 19
Not applicableNot Yet RecruitingNCT07287904What this trial is testingPrediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal DataWho this might be right forLung Cancer (NSCLC)EGFR Activating MutationAdenocarcinoma Lung+1 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07508852What this trial is testing68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung CancerWho this might be right forSCLCSCLC, Extensive StageSCLC, Limited Stage+2 more Peking University First Hospital 30
Early research (Phase 1)Study completedNCT00455052What this trial is testingIntravenous XMT-1001 in Patients With Advanced Solid TumorsWho this might be right forSmall Cell Lung CancerNon-small Cell Lung Cancer Mersana Therapeutics 30
Not applicableUnknownNCT03908671What this trial is testingClinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung CancerWho this might be right forEsophageal CancerNon Small Cell Lung Cancer Stemirna Therapeutics 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05096663What this trial is testingTesting the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)Who this might be right forAdvanced Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more SWOG Cancer Research Network 82
Testing effectiveness (Phase 2)Ended earlyNCT00958321What this trial is testingPositron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35Who this might be right forLung CancerMetastatic Cancer Cancer Trials Ireland 40
Not applicableStudy completedNCT00198406What this trial is testingA FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.Who this might be right forELDERLY PEOPLENon-small Cell Lung Cancer Intergroupe Francophone de Cancerologie Thoracique 1,653
Testing effectiveness (Phase 2)Study completedNCT03184571What this trial is testingBemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)Who this might be right forLung Cancer MetastaticNSCLC Stage IVAdenocarcinoma of Lung BerGenBio ASA 99
Early research (Phase 1)Looking for participantsNCT06955988What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forLocally Advanced or Metastatic Non-small Cell Lung Cancer Allist Pharmaceuticals, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT02448303What this trial is testingPembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Acerta Pharma BV 74
Testing effectiveness (Phase 2)Looking for participantsNCT07230405What this trial is testingA Phase II Study of SKB571 in Patients With Lung CancerWho this might be right forLung Cancer (Non-Small Cell) Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 295
Testing effectiveness (Phase 2)Active Not RecruitingNCT04533451What this trial is testingTesting the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung CancerWho this might be right forMetastatic Lung AdenocarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Adenocarcinoma+4 more Alliance for Clinical Trials in Oncology 101
Testing effectiveness (Phase 2)Study completedNCT00173875What this trial is testingIressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer National Taiwan University Hospital 108
Not applicableStudy completedNCT06638957What this trial is testingImpact of the COVID-19 Pandemic on Oncologic Outcomes in Colorectal CancerWho this might be right forColorectal CarcinomaCOVID 19 In Ja Park 14,951
Early research (Phase 1)UnknownNCT03871205What this trial is testingNeoantigen-primed DC Vaccines Therapy for Refractory Lung CancerWho this might be right forCarcinoma, Non-Small Cell LungCarcinoma, Small Cell Lung Shenzhen People's Hospital 30
Early research (Phase 1)Active Not RecruitingNCT05783622What this trial is testingStudy of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forNon-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more Janux Therapeutics 130